Sign in
Taking people in United StatesPhase 1

Study of NTX-2001 on Alcohol Consumption in Alcohol Use Disorder

Key facts

Who runs it
Newleos Therapeutics, Inc.
Where
New Haven, United StatesSee the site
Trial code
Status
Recruiting
Phase
Phase 1
People taking part
50 people, planned
Started
20 Mar 2026
Expected to end
Mar 2027
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • NTX-2001
  • Placebo
Record updated
9 April 2026

Who can take part

Age
21 years to 60 years
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (15)Hide the full registry criteria

Who can take part

  • Has provided written informed consent for the study and is willing to comply with all requirements of the protocol
  • English speaker
  • Male or female, ≥21 and ≤60 years of age
  • Has a body mass index (BMI) 18 to 35 kg/m2 inclusive
  • Meets DSM-5 criteria for Alcohol Use Disorder (AUD) confirmed by Mini-International Neuropsychiatric Interview (MINI)
  • If participant is of childbearing potential, must commit to practicing highly effective methods of birth control during the study and at least 14 days after the last dose

Who cannot take part

  • Receiving psychotropics regularly, except for a stable dose of an antidepressant for at least 2 months prior to Screening
  • Current diagnosis of substance use disorder, except for tobacco use disorder or mild cannabis use disorder as defined by the Diagnostic and Statistical Manual of Mental Disorders 5th Edition (DSM-5)
  • Past or current diagnosis of schizophrenia spectrum or other psychotic disorder as defined by the DSM-5
  • Has moderate or severe hepatic impairment
  • Has moderate or severe renal impairment
  • Currently seeking alcohol treatment or have been in alcohol treatment within the past 6 months
  • Reports disliking spirits (hard liquor)
  • Is at risk for suicidal ideation as per C-SSRS
  • Women who are pregnant or women who are currently breastfeeding unless they plan to stop breastfeeding for the duration of the study

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Alcohol use disorder

This trial is currently available in United States.

  • Yale University School of Medicine, Connecticut Mental Health CenterNew Haven, United StatesContact: Yale University School of Medicine, Connecticut Mental HealthTaking people

About the trial

What the trial wants to find out

The primary goal of this Phase 1b clinical trial is to evaluate the effects of a novel TAAR1 receptor partial agonist (NTX-2001) in adults with Alcohol Use Disorder (AUD). The main questions this trial aims to answer are:

Read full original descriptionShow less

* Does NTX-2001 affect alcohol consumption in adults with AUD? * Is NTX-2001 safe and well tolerated in adults with AUD?

Researchers will compare the effects of NTX-2001 with matching placebo (look-alike capsule that contains no drug).

Participants will:

* Take NTX-2001 or matching placebo every day for 2 weeks * Visit the clinic 4 times over the course of 10 weeks

The 2 groups in the trial

  • NTX-2001Treatment being tested
  • PlaceboPlacebo, for comparison

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
The Effects of NTX-2001, a Novel TAAR1 Partial Agonist, on Alcohol Consumption in Adults With Alcohol Use Disorder: A Phase 1b, Randomized, Placebo-Controlled, Proof-of-Concept Study
Criteria questions
Built from NCT07520292, who can take part
Record updated
9 April 2026